Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference
DEERFIELD, IL -- (Marketwired) -- 02/04/14 -- Horizon Pharma, Inc.
(NASDAQ: HZNP) today announced Timothy P. Walbert, chairman,
president and chief executive officer, is scheduled to present at the
16th Annual BIO CEO and Investor Conference on Tuesday, February 11,
2014 at 2:00pm Eastern Time in New York, NY. Mr. Walbert will provide
an overview of the Company and its corporate activities.
The presentation will be webcast live and may be accessed by visiting
Horizon's website at http://ir.horizon-pharma.com. A replay of the
webcast will be available for 10 business days.
About Horizon Pharma
Horizon Pharma, Inc. is a commercial stage,
specialty pharmaceutical company that markets DUEXIS(R),
RAYOS(R)/LODOTRA(R) and VIMOVO(R), which target unmet therapeutic
needs in arthritis, pain and inflammatory diseases. The Company's
strategy is to develop, acquire or in-license additional innovative
medicines or companies where it can execute a targeted commercial
approach among specific target physicians such as primary care
physicians, orthopedic surgeons and rheumatologists, while taking
advantage of its commercial strengths and the infrastructure the
Company has put in place. For more information, please visit
Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Press spacebar to pause and continue. Press esc to stop.